Caspase recruitment domains. New potential markers for diagnosis of hepatocellular carcinoma associated with HCV in Egyptian patients

Dienstag, 2006, American gastroenterological association medical position statement on the management of hepatitis C, Gastroenterol, 130, 225, 10.1053/j.gastro.2005.11.011 Motola-Kuba, 2006, Hepatocellular carcinoma. An overview, Ann Hepatol, 5, 16, 10.1016/S1665-2681(19)32034-4 Abdel-Aziz, 2000, Hepatitis C virus (HCV) infection in a community in the Nile Delta: population description and HCV prevalence, Hepatol, 32, 111, 10.1053/jhep.2000.8438 Pawson, 2000, Protein-protein interactions define specificity in signal transduction, Genes Deviation, 14, 1027, 10.1101/gad.14.9.1027 Chu, 2001, A novel enhancer of the Apaf1 apoptosome involved in cytochrome c-dependent caspase activation and apoptosis, J Biol Chem, 276, 9239, 10.1074/jbc.M006309200 Roberts, 2006, Caspase recruitment domain containing protein 15 mutations in patients with colorectal cancer, Can Res, 66, 2532, 10.1158/0008-5472.CAN-05-4165 Karin, 2000, Phosphorylation meets ubiquitination: the control of NF-[kappa] B activity, Annu Rev Immunol, 18, 621, 10.1146/annurev.immunol.18.1.621 Jihua, 2001, BCL10 gene mutation in Hepatocellular carcinoma, J Chin Med, 114, 747 Wang, 2005, apoptosis repressor with caspase recruitment domain (ARC) is expressed in cancer cells and localizes to nuclei, FEBS, 579, 2411, 10.1016/j.febslet.2005.03.040 McConnell, 2000, Activation of Caspase-9-mediated apoptotic pathway by subcellular redistribution of the novel caspase recruitment domain protein TMS1, Can Res, 60, 6243 Ishak, 1995, Histological grading and staging of chronic hepatitis, J Hepatol, 22, 696, 10.1016/0168-8278(95)80226-6 Bruix, 2004, Focus on hepatocellular carcinoma, Can Cell, 5, 215, 10.1016/S1535-6108(04)00058-3 Bruix, 2001, Clinical management of hepatocellular carcinoma: conclusions of the Barcelona- 2000 EASL conference, J Hepatol, 35, 421, 10.1016/S0168-8278(01)00130-1 Salomao, 2012, Recent advances in the classification of hepatocellular carcinoma, Diagnostic Histopathology, 18, 37, 10.1016/j.mpdhp.2011.12.001 Zekri, 2012, Molecular Prognostic Profile of Egyptian HCC Cases Infected with Hepatitis C Virus, Asian Pas J Cancer Prev, 13, 5433, 10.7314/APJCP.2012.13.11.5433 Nakamura, 2005, Overexpression of caspase recruitment domain (CARD) membrane-associated guanylate kinase 1 (CARMA1) and CARD9 in primary gastric B-cell lymphoma, Can, 104, 1885 Soung, 2006, Mutational analysis of proapoptotic caspase-9 gene in common human carcinomas, APMIS, 114, 292, 10.1111/j.1600-0463.2006.apm_364.x Park, 2006, Caspase 9 promoter polymorphisms and risk of primary lung cancer, Hum Mol Genet, 15, 1963, 10.1093/hmg/ddl119 Hosgood, 2008, Caspase polymorphisms and genetic susceptibility to multiple myeloma, Hematol Oncol, 26, 148, 10.1002/hon.852 Qiu, 2012, Association of TNF-a promoter polymorphism with the outcome of persistent HBV infection in a northeast Chinese Han population, Act Biochim Biophys Sin(Shanghai), 44, 712 Kischkel, 2001, Death receptor recruitment of endogenous caspase-10 and apoptosis initiation in the absence of caspase-8, J Biol Chem, 276, 46639, 10.1074/jbc.M105102200 Proell, 2013, The CARD plays a critical role in ASC foci formation and inflammasome signalling, Biochem J, 449, 613, 10.1042/BJ20121198 Walter, 2011, Risk factors for hepatocellular carcinoma in a cohort infected with hepatitis B or hepatitis C, J Hepatol Gastroenterol, 10, 1440 Soliman, 2010, Epidemiologic risk factors of hepatocellular carcinoma in a rural region of Egypt, Int J Hepatol, 4, 681, 10.1007/s12072-010-9187-1 Abdel-Wahab, 2007, Epidemiology of hepatocellular carcinoma in lower Egypt, Mansoura Gastroenterology Center, Hepatogastroenterology, 54, 157 Mummadi, 2010, Role of simple biomarkers in predicting fibrosis progression in HCV infection, World J Gastroenterol, 16, 5705, 10.3748/wjg.v16.i45.5710 Yu, 2011, Alkaline Phosphatase: Does it have a Role in Predicting Hepatocellular Carcinoma Recurrence, World J Gastrointest Surg, 15, 1440, 10.1007/s11605-011-1537-3 Chen, 2007, Predictors of alpha-fetoprotein elevation in patients with chronic hepatitis C, but not hepatocellular carcinoma, and its normalization after pegylated interferon alfa 2a-ribavirin combination therapy, Gastroenterol Hepatol, 22, 669, 10.1111/j.1440-1746.2007.04898.x